Richard E. Buller - 24 Apr 2024 Form 4 Insider Report for Celcuity Inc. (CELC)

Role
Director
Signature
/s/ Liz Dunshee as Attorney-in-Fact for Richard E. Buller pursuant to Power of Attorney filed herewith.
Issuer symbol
CELC
Transactions as of
24 Apr 2024
Transactions value $
-$5,971
Form type
4
Filing time
26 Apr 2024, 16:55:07 UTC
Previous filing
10 Apr 2024
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELC Common Stock Sale -$5.97K -350 -4.33% $17.06 7.73K 24 Apr 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CELC Stock Option (right to buy) 4.56K 24 Apr 2024 Common Stock 4.56K $5.50 By Trust F3, F4
holding CELC Stock Option (right to buy) 12.7K 24 Apr 2024 Common Stock 12.7K $5.10 By Trust F3, F4
holding CELC Stock Option (right to buy) 2.31K 24 Apr 2024 Common Stock 2.31K $5.50 By Trust F3, F4
holding CELC Stock Option (right to buy) 19.6K 24 Apr 2024 Common Stock 19.6K $5.50 By Trust F3, F4
holding CELC Stock Option (right to buy) 8.73K 24 Apr 2024 Common Stock 8.73K $9.58 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2023.
F2 Includes 1,958 shares of restricted stock for which risks of forfeiture lapse on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.
F3 100% vested.
F4 The Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.
F5 This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.